Sinphar Pharmaceutical Co (TPE:1734) Construction In Progress: NT$59 Mil (As of Dec. 2025)


TPE:1734 Sinphar Pharmaceutical Co Ltd TPE:1734
80 GF Score
Price NT$32.65
GF Value NT$33.14
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Sinphar Pharmaceutical Co Construction In Progress?

Sinphar Pharmaceutical Co TPE:1734 -0.15% 80 Construction In Progress is NT$59 Mil as of Dec. 2025. GuruFocus rates TPE:1734 with a GF Score™ of 80/100 and a GF Value™ of NT$33.14 (Fairly Valued). The stock has 1 warning sign investors should review.

Sinphar Pharmaceutical Co's quarterly construction in progress increased from Jun. 2025 (NT$57 Mil) to Sep. 2025 (NT$84 Mil) but then declined from Sep. 2025 (NT$84 Mil) to Dec. 2025 (NT$59 Mil).

Sinphar Pharmaceutical Co's annual construction in progress declined from Dec. 2023 (NT$31 Mil) to Dec. 2024 (NT$31 Mil) but then increased from Dec. 2024 (NT$31 Mil) to Dec. 2025 (NT$59 Mil).

Sinphar Pharmaceutical Co Construction In Progress Historical Data

* Premium members only.

The historical data trend for Sinphar Pharmaceutical Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinphar Pharmaceutical Co Construction In Progress Chart

Sinphar Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.06 65.08 30.86 30.70 58.53

Sinphar Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.70 46.11 56.56 83.57 58.53
TPE:1734
80GF Score
Sinphar Pharmaceutical Co Ltd TPE:1734
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sinphar Pharmaceutical Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of NT$59 Mil mean?
Sinphar Pharmaceutical Co (TPE:1734) has a Construction In Progress of NT$59 Mil as of Dec. 2025. Construction in Progress records the amount of construction work that is not complete. View historical data on Sinphar Pharmaceutical Co and its competitors.
Is Sinphar Pharmaceutical Co's Construction In Progress too high?
Sinphar Pharmaceutical Co's current Construction In Progress is NT$59 Mil. Overall, Sinphar Pharmaceutical Co has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sinphar Pharmaceutical Co's Construction In Progress compare to VRTX and REGN?
Sinphar Pharmaceutical Co's Construction In Progress of NT$59 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Sinphar Pharmaceutical Co and its competitors. Sinphar Pharmaceutical Co's current Construction In Progress is NT$59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinphar Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Sinphar Pharmaceutical Co (TPE:1734) is currently considered Fairly Valued. The stock's GF Value™ is NT$33.14, compared to a current price of NT$32.65 — trading 1.5% below its estimated fair value. The current Construction In Progress is NT$59 Mil. Sinphar Pharmaceutical Co's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Sinphar Pharmaceutical Co (TPE:1734), the current Construction In Progress is NT$59 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sinphar Pharmaceutical Co (TPE:1734) Overvalued in 2026?

Based on GuruFocus' analysis, Sinphar Pharmaceutical Co stock appears to be undervalued. The current stock price of NT$32.65 is trading 1.5% below its estimated GF Value™ of NT$33.14. GuruFocus considers Sinphar Pharmaceutical Co to be Fairly Valued.

Key valuation signals for TPE:1734:

  • Construction In Progress: NT$59 Mil
  • GF Value™: NT$33.14 vs. price of NT$32.65 (1.5% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the TPE:1734 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sinphar Pharmaceutical Co Business Description

Address No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269
Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.
80GF Score

Get the complete analysis for TPE:1734

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.65
Price
NT$33.14
GF Value